PolyPeptide Group AG (XSWX:PPGN) General and Admin. Expense: CHF24.8 Mil (TTM As of Dec. 2025)


XSWX:PPGN PolyPeptide Group AG XSWX:PPGN
73 GF Score
Price CHF49.40
GF Value CHF30.82
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is PolyPeptide Group AG General and Admin. Expense?

PolyPeptide Group AG XSWX:PPGN +2.07% 73 General and Admin. Expense is CHF24.8 Mil as of Dec. 2025. GuruFocus rates XSWX:PPGN with a GF Score™ of 73/100 and a GF Value™ of CHF30.82 (Significantly Overvalued). The stock has 9 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. PolyPeptide Group AG's General and Admin. Expense for the six months ended in Dec. 2025 was CHF1.4 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF24.8 Mil.

PolyPeptide Group AG General and Admin. Expense Related Terms

PolyPeptide Group AG General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG General and Admin. Expense Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial 14.44 16.72 16.20 18.81 24.69

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.69 19.96 -0.56 23.44 1.38
XSWX:PPGN
73GF Score
PolyPeptide Group AG XSWX:PPGN
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF24.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of CHF24.8 Mil mean?
PolyPeptide Group AG (XSWX:PPGN) has a General and Admin. Expense of CHF24.8 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on PolyPeptide Group AG and its competitors.
Is PolyPeptide Group AG's General and Admin. Expense too high?
PolyPeptide Group AG's current General and Admin. Expense is CHF24.8 Mil. Overall, PolyPeptide Group AG has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's General and Admin. Expense compare to ZTS and UTHR?
PolyPeptide Group AG's General and Admin. Expense of CHF24.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on PolyPeptide Group AG and its competitors. PolyPeptide Group AG's current General and Admin. Expense is CHF24.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (XSWX:PPGN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF30.82, compared to a current price of CHF49.40 — trading 60.3% above its estimated fair value. The current General and Admin. Expense is CHF24.8 Mil. PolyPeptide Group AG's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For PolyPeptide Group AG (XSWX:PPGN), the current General and Admin. Expense is CHF24.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (XSWX:PPGN) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of CHF49.40 is trading 60.3% above its estimated GF Value™ of CHF30.82. GuruFocus considers PolyPeptide Group AG to be Significantly Overvalued.

Key valuation signals for XSWX:PPGN:

  • General and Admin. Expense: CHF24.8 Mil
  • GF Value™: CHF30.82 vs. price of CHF49.40 (60.3% above fair value)
  • GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the XSWX:PPGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
73GF Score

Get the complete analysis for XSWX:PPGN

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF49.40
Price
CHF30.82
GF Value